Skip Nav Destination
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy
Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial
A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
Issue Archive
February 17 2011
In this Issue
Table of Contents
Inside blood
Blood Work
Perspectives
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model
Clinical Trials & Observations
Neil A. Goldenberg,Alex C. Spyropoulos,Jonathan L. Halperin,Craig M. Kessler,Sam Schulman,Alexander G. G. Turpie,Allan M. Skene,Neal R. Cutler,William R. Hiatt,for the Antithrombotic Trials Leadership and Steering Group
Review Articles
Hematopoiesis and Stem Cells
Immunobiology
B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice
Yuanyuan Chu,J. Christoph Vahl,Dilip Kumar,Klaus Heger,Arianna Bertossi,Edyta Wójtowicz,Valeria Soberon,Dominik Schenten,Brigitte Mack,Miriam Reutelshöfer,Rudi Beyaert,Kerstin Amann,Geert van Loo,Marc Schmidt-Supprian
Lymphoid Neoplasia
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy
Clinical Trials & Observations
Christian Straka,Michael Sandherr,Hans Salwender,Hannes Wandt,Bernd Metzner,Kai Hübel,Gerda Silling,Marcus Hentrich,Daniel Franke,Rainer Schwerdtfeger,Mathias Freund,Orhan Sezer,Alexander Giagounidis,Gerhard Ehninger,Wolfgang Grimminger,Andreas Engert,Günter Schlimok,Christof Scheid,Peter Hellmann,Harald Heinisch,Hermann Einsele,Axel Hinke,Bertold Emmerich
Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial
Clinical Trials & Observations
Hannah M. Ensor,Claire Schwab,Lisa J. Russell,Sue M. Richards,Heather Morrison,Dino Masic,Lisa Jones,Sally E. Kinsey,Ajay J. Vora,Christopher D. Mitchell,Christine J. Harrison,Anthony V. Moorman
Myeloid Neoplasia
A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
Clinical Trials & Observations
Saiko Kurosawa,Takuhiro Yamaguchi,Shuichi Miyawaki,Naoyuki Uchida,Heiwa Kanamori,Kensuke Usuki,Takuya Yamashita,Masato Watanabe,Kazuaki Yakushiji,Shingo Yano,Yuichiro Nawa,Jun Taguchi,Jin Takeuchi,Junji Tomiyama,Yuko Nakamura,Ikuo Miura,Yoshinobu Kanda,Yoichi Takaue,Takahiro Fukuda
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
Clinical Trials & Observations
Sabine Kayser,Konstanze Döhner,Jürgen Krauter,Claus-Henning Köhne,Heinz A. Horst,Gerhard Held,Marie von Lilienfeld-Toal,Sibylla Wilhelm,Andrea Kündgen,Katharina Götze,Mathias Rummel,David Nachbaur,Brigitte Schlegelberger,Gudrun Göhring,Daniela Späth,Carina Morlok,Manuela Zucknick,Arnold Ganser,Hartmut Döhner,Richard F. Schlenk,for the German-Austrian AMLSG
Phagocytes, Granulocytes, and Myelopoiesis
Platelets and Thrombopoiesis
Red Cells, Iron, and Erythropoiesis
Thrombosis and Hemostasis
Proteolytic antibodies activate factor IX in patients with acquired hemophilia
Bharath Wootla,Olivier D. Christophe,Ankit Mahendra,Jordan D. Dimitrov,Yohann Repessé,Véronique Ollivier,Alain Friboulet,Annie Borel-Derlon,Hervé Levesque,Jeanne-Yvonne Borg,Sebastien Andre,Jagadeesh Bayry,Thierry Calvez,Srinivas V. Kaveri,Sébastien Lacroix-Desmazes
Transplantation
Vascular Biology
-
Cover Image
Cover Image
The crystal structure of LMO2 in complex with the LID domain of LDB1 (right) and overexpression strategy in zebrafish (left) reveal the importance of the conformational flexibility of LMO2 for binding to its partner protein SCL/TAL1 in vivo. See the article by El Omari et al on page 2146.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals